|Articles|June 22, 2017
PAREXEL is Acquired by Pamplona Capital Management
Advertisement
PAREXEL International Corporation announced that Pamplona Capital Management, LLP has acquired all of its outstanding shares, including Parexel's net debt, for $88.10 per share in cash-valued at approximately $5 billion.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
If You Build It ... Will They Come?
2
Congressional Funding Deal Boosts Research Space Ahead of Shutdown Deadline
3
FDA RWE Guidance Redefines Data Use in Clinical Operations
4
The Business Case for DEI in Pharmaceutical Innovation: Why Organizational Commitment Matters for Inclusive Clinical Trials
5